and Movement Disorders
234 Goodman Street, Cincinnati, Ohio 45219 | (866) 941-UCNI (8264)
Gardner Center for Parkinson's Disease
Press Releases
RSS FeedVirtual Tours
UCNI Part of Trial that Studies New Way to Deliver Parkinson's Medication
Thursday, August 5, 2010
CINCINNATI—Most medications for Parkinson’s disease are taken orally, at certain times of the day. But doctors at the University of Cincinnati Neuroscience Institute are participating in a clinical trial that significantly changes the Parkinson’s drug-delivery model. Read more »
* * *
The UC Neuroscience Institute, a regional center of excellence, is dedicated to patient care, research, education, and the development of new treatments for stroke, brain and spinal tumors, epilepsy, traumatic brain and spinal injury, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, disorders of the senses (swallowing, voice, hearing, pain, taste and smell), and psychiatric conditions (bipolar disorder, schizophrenia, and depression).
Search
Educational Conferences
Dale’s Hope Story: Parkinson's
After being diagnosed with Parkinson’s disease in 2003, 46-year-old Dale Ankenman was determined not to let it keep him off his bike. Considering his long list of credentials, including qualified former U.S. Navy Submariner, Army Ranger, scuba diver and parachutist, he wasn’t used to the idea of something he could not physically conquer.
Read More »